Healthstream (HSTM) Cash from Financing Activities (2010 - 2026)

Healthstream (HSTM) has reported Cash from Financing Activities for 17 consecutive years, with -$4.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash from Financing Activities rose 78.97% year-over-year to -$4.0 million in Q2 2026; TTM through Jun 2026 was -$27.5 million, a 19.46% decrease from a year earlier, with the FY2025 full-year figure at -$36.3 million, down 703.08% from the prior year.
• Cash from Financing Activities was -$4.0 million for Q2 2026 at Healthstream, up from -$8.3 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at -$20000.0 in Q3 2022 and troughed at -$20.2 million in Q1 2022.
• A 5-year average of -$5.0 million and a median of -$2.2 million in 2023 frame the typical range for Cash from Financing Activities.
• Across the five-year window, Cash from Financing Activities soared 99.18% in 2022 and plunged 17502.13% in 2023, its largest moves.
• Over 5 years, Cash from Financing Activities stood at -$47000.0 in 2022, then sank by 17502.13% to -$8.3 million in 2023, then surged by 87.51% to -$1.0 million in 2024, then slumped by 601.26% to -$7.2 million in 2025, then surged by 44.63% to -$4.0 million in 2026.
• The last three Cash from Financing Activities figures came in at -$4.0 million (Q2 2026), -$8.3 million (Q1 2026), and -$7.2 million (Q4 2025), per Business Quant data.